The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program.
about
Multiple cancer testis antigens function to support tumor cell mitotic fidelity.Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway.The mesh is a network of microtubule connectors that stabilizes individual kinetochore fibers of the mitotic spindle.High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4miR-30e controls DNA damage-induced stress responses by modulating expression of the CDK inhibitor p21WAF1/CIP1 and caspase-3.Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).Pulling it together: The mitotic function of TACC3.Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy.PKCι depletion initiates mitotic slippage-induced senescence in glioblastomaOncogenic FGFR3 gene fusions in bladder cancer.Centrosome aberrations associated with cellular senescence and p53 localization at supernumerary centrosomes.Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy.FGFR3-TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindleThe centrosomal adaptor TACC3 and the microtubule polymerase chTOG interact via defined C-terminal subdomains in an Aurora-A kinase-independent manner.TACC3 in personalized medicineTACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis.Clinicopathological and prognostic value of transforming acidic coiled-coil-containing protein 3 (TACC3) expression in soft tissue sarcomas.Disruption of Tacc3 function leads to in vivo tumor regression.Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling
P2860
Q29871492-506DE0C8-A880-4D9A-A75F-230A8665B845Q34662199-F4AE7AA6-F520-4E58-A1E1-1C03EF3D3B55Q35668564-00C9D7EE-EA61-4CCF-90C7-937364AB73F9Q35740091-AFE9071F-76F1-4C40-870C-752D563C2991Q36802020-42864F6F-FFD0-45D9-9B10-D6282D3C0869Q37085916-C7A2B19E-C282-45E8-9758-53E7199CEA31Q37492314-CACC8B78-7252-4CA2-B32B-37D86F6D583BQ37933071-717DF801-7010-4CE6-B857-E0F84213121AQ38894287-5BB70224-1CDE-47CD-B90B-345CBDF89A9DQ38981503-07344347-3C3D-4308-8FBD-2A71952EC197Q39240290-B92A87E3-1D9B-443F-AC49-3AF334A2D895Q39254584-2296CF52-4FB7-418F-9152-A4D463067533Q39456292-2E4909FE-4BC7-4CFE-83D1-C9E84A784350Q41567166-10C447D8-1009-46B5-8852-6771F89D7FF8Q41848433-1CD4705C-83B3-4D28-9E07-FA94CF250AF4Q42087478-A4EDE5DF-897D-4C62-AC2B-8267CE1BC88DQ43050437-5EC3998D-AE50-477A-A8DC-A135BC18ACFBQ45994976-D99F5E66-3294-407E-983C-C670946FEC69Q52612716-4120C10E-CA9D-4ECF-AFE1-E5E40D226676Q53204532-6D959B2E-3614-4916-9BA0-A5471037661CQ57821064-2C132768-2A42-4D14-8686-6F8BEE395CFB
P2860
The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The centrosomal protein TACC3 ...... premature senescence program.
@en
The centrosomal protein TACC3 ...... premature senescence program.
@nl
type
label
The centrosomal protein TACC3 ...... premature senescence program.
@en
The centrosomal protein TACC3 ...... premature senescence program.
@nl
prefLabel
The centrosomal protein TACC3 ...... premature senescence program.
@en
The centrosomal protein TACC3 ...... premature senescence program.
@nl
P2093
P2860
P356
P1433
P1476
The centrosomal protein TACC3 ...... premature senescence program.
@en
P2093
B Nürnberg
H Hanenberg
I C Cirstea
K Schulze-Osthoff
M R Ahmadian
R P Piekorz
P2860
P2888
P304
P356
10.1038/ONC.2010.354
P407
P577
2010-08-23T00:00:00Z